• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新的全球多囊卵巢综合征指南将如何改变我们的临床实践?

How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?

作者信息

Jacob Susie, Balen Adam H

机构信息

Leeds Fertility, Seacroft Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

出版信息

Clin Med Insights Reprod Health. 2019 Jul 3;13:1179558119849605. doi: 10.1177/1179558119849605. eCollection 2019.

DOI:10.1177/1179558119849605
PMID:31320811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610395/
Abstract

Polycystic ovary syndrome (PCOS) is a far reaching condition that has a number of reproductive and general health implications. There has been much debate in recent years about the diagnosis and definition of PCOS and a plethora of studies assessing its management, ranging from the psychosocial aspects of the conditions, to the treatment of hyperandrogenism, anovulatory infertility, and the long-term metabolic and reproductive consequences. There has been a need to synthesise the evidence and produce an international consensus guideline for all aspects of the management of PCOS and this was achieved with the publication of the . The guideline is broadly categorised into 5 sections, which focus on diagnosis, holistic management and safe, effective fertility treatment. This article summarises the key points of the guidance and brings the management of PCOS up to date for the 21st century.

摘要

多囊卵巢综合征(PCOS)是一种影响广泛的病症,对生殖健康和整体健康都有诸多影响。近年来,关于PCOS的诊断和定义存在诸多争议,并且有大量研究评估其管理方法,涵盖了从该病症的心理社会层面到高雄激素血症、无排卵性不孕症的治疗,以及长期代谢和生殖后果等方面。一直以来都需要综合相关证据,并制定一份关于PCOS管理各方面的国际共识指南,而随着《[指南名称未给出]》的发表这一目标得以实现。该指南大致分为5个部分,重点关注诊断、整体管理以及安全有效的生育治疗。本文总结了该指南的要点,并使PCOS的管理跟上21世纪的最新进展。

相似文献

1
How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?新的全球多囊卵巢综合征指南将如何改变我们的临床实践?
Clin Med Insights Reprod Health. 2019 Jul 3;13:1179558119849605. doi: 10.1177/1179558119849605. eCollection 2019.
2
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.多囊卵巢综合征患者排卵障碍性不孕的管理:支持制定全球世卫组织指南的证据分析。
Hum Reprod Update. 2016 Nov;22(6):687-708. doi: 10.1093/humupd/dmw025. Epub 2016 Aug 10.
3
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.多囊卵巢综合征评估与管理国际循证指南:不孕症评估与治疗的证据总结及建议
Hum Reprod Open. 2019 Jan 4;2019(1):hoy021. doi: 10.1093/hropen/hoy021. eCollection 2019.
4
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
5
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.多囊卵巢综合征评估与管理的国际循证指南推荐意见。
Clin Endocrinol (Oxf). 2018 Sep;89(3):251-268. doi: 10.1111/cen.13795. Epub 2018 Jul 19.
6
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.国际循证指南关于多囊卵巢综合征评估和管理的推荐意见。
Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.
7
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Fertil Steril. 2023 Oct;120(4):767-793. doi: 10.1016/j.fertnstert.2023.07.025. Epub 2023 Aug 14.
8
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见†。
Hum Reprod. 2023 Sep 5;38(9):1655-1679. doi: 10.1093/humrep/dead156.
9
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.多囊卵巢综合征评估与管理的国际循证指南推荐意见。
Hum Reprod. 2018 Sep 1;33(9):1602-1618. doi: 10.1093/humrep/dey256.
10
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Eur J Endocrinol. 2023 Aug 2;189(2):G43-G64. doi: 10.1093/ejendo/lvad096.

引用本文的文献

1
Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment.中国多专科医生对多囊卵巢综合征治疗与管理的偏好和认知:调查与离散选择实验
Adv Ther. 2025 Aug 8. doi: 10.1007/s12325-025-03311-7.
2
Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins.定量蛋白质组学揭示了基于铁死亡蛋白的多囊卵巢综合征女性子宫内膜的预后特征。
Front Endocrinol (Lausanne). 2022 Jul 14;13:871945. doi: 10.3389/fendo.2022.871945. eCollection 2022.
3
Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.诊断延误:35 岁前未经诊断的多囊卵巢综合征女性与临床诊断患者的健康特征差异。
Hum Reprod. 2021 Jul 19;36(8):2275-2284. doi: 10.1093/humrep/deab101.
4
PTEN: A Thrifty Gene That Causes Disease in Times of Plenty?PTEN:一个在富足时代引发疾病的节俭基因?
Front Nutr. 2020 Jun 5;7:81. doi: 10.3389/fnut.2020.00081. eCollection 2020.

本文引用的文献

1
Ethnic-specific polycystic ovary syndrome: epidemiology, significance and implications.特定种族的多囊卵巢综合征:流行病学、意义及影响
Expert Rev Endocrinol Metab. 2013 Jan;8(1):71-79. doi: 10.1586/eem.12.73.
2
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.芳香化酶抑制剂(来曲唑)用于多囊卵巢综合征的不孕女性。
Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3.
3
Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome.雄激素过多型多囊卵巢综合征学会:多囊卵巢综合征患者抑郁、焦虑、生活质量和饮食障碍的立场声明。
Fertil Steril. 2018 May;109(5):888-899. doi: 10.1016/j.fertnstert.2018.01.038.
4
Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.多囊卵巢综合征中种族、肥胖与葡萄糖耐量受损及 2 型糖尿病患病率的关系:系统评价与荟萃回归分析。
Hum Reprod Update. 2018 Jul 1;24(4):455-467. doi: 10.1093/humupd/dmy007.
5
Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.低脂饮食与低碳水化合物饮食对超重成年人12个月体重减轻的影响以及与基因型模式或胰岛素分泌的关联:DIETFITS随机临床试验
JAMA. 2018 Feb 20;319(7):667-679. doi: 10.1001/jama.2018.0245.
6
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
7
Optimizing preconception health in women of reproductive age.优化育龄女性的孕前健康。
Minerva Ginecol. 2018 Feb;70(1):99-119. doi: 10.23736/S0026-4784.17.04140-5. Epub 2017 Sep 12.
8
Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.多囊卵巢综合征的生活方式与行为管理
J Womens Health (Larchmt). 2017 Aug;26(8):836-848. doi: 10.1089/jwh.2016.5792. Epub 2017 Jun 1.
9
Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials.多囊卵巢综合征患者无排卵的肌醇治疗:随机试验的荟萃分析。
BJOG. 2018 Feb;125(3):299-308. doi: 10.1111/1471-0528.14754. Epub 2017 Jul 14.
10
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征中中度和重度抑郁及焦虑症状的高患病率:一项系统评价和荟萃分析。
Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044.